Felix Brann

Felix Brann is the Chief Executive Officer at Pharos, an emerging healthcare technology company focused on deploying artificial intelligence for clinical decision support and disease management. Prior to his current executive position, he served as the Vice President of Data Science at vital.io, where he directed initiatives applying advanced analytics and machine learning directly to complex medical data. Before transitioning into the health technology sector, Brann worked extensively in the global financial services industry as the Vice President of Quantitative Research at JP Morgan. In January 2024, he co-authored and published peer-reviewed medical research evaluating artificial intelligence applications for sepsis diagnosis and prediction in the Journal of Medical Internet Research. His current focus centers on bridging quantitative finance methodologies with clinical data science to engineer predictive algorithms that address critical healthcare challenges like early sepsis detection.